Literature DB >> 15561448

Applicability of the Fagerström Test for Nicotine Dependence in smokers with schizophrenia.

Marc L Steinberg1, Jill M Williams, Howard R Steinberg, Jonathan A Krejci, Douglas M Ziedonis.   

Abstract

Up to 90% of individuals with schizophrenia smoke cigarettes, and many show signs of heavy dependence. Although the severity of nicotine dependence is often measured by the six-item Fagerstrom Test for Nicotine Dependence (FTND), this measure, in its current form, may not be as appropriate in this population--or in others who's smoking is regulated by others--as in the general population due to differences in smoking patterns, living arrangements, and daily routines. These factors may produce an underestimate of nicotine dependence, which may have clinical implications for successful medical detoxification if the FTND scores are used to guide the dosage of nicotine replacement medication. Data indicate poor internal consistency reliability (alpha=.4581) and a factor pattern lacking simple structure (i.e., two nonmeaningful factors/components with substantial cross loadings) when administered to smokers with schizophrenia. Specific examples of problematic items and how these may contribute to an underestimate of tobacco dependence severity are discussed, as well as ways to modify the FTND to be more appropriate for this population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15561448     DOI: 10.1016/j.addbeh.2004.04.012

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  17 in total

1.  Tobacco craving in smokers with and without schizophrenia.

Authors:  Suzanne Lo; Stephen J Heishman; Heather Raley; Katherine Wright; Heidi J Wehring; Eric T Moolchan; Stephanie Feldman; Fang Liu; Robert P McMahon; Charles M Richardson; Deanna L Kelly
Journal:  Schizophr Res       Date:  2010-07-15       Impact factor: 4.939

2.  Illicit drug use in heavy smokers with and without schizophrenia.

Authors:  Kristen M Mackowick; Stephen J Heishman; Heidi J Wehring; Fang Liu; Robert P McMahon; Deanna L Kelly
Journal:  Schizophr Res       Date:  2012-05-14       Impact factor: 4.939

3.  Effects of smoking abstinence, smoking cues and nicotine replacement in smokers with schizophrenia and controls.

Authors:  Jennifer W Tidey; Damaris J Rohsenow; Gary B Kaplan; Robert M Swift; Amy B Adolfo
Journal:  Nicotine Tob Res       Date:  2008-06       Impact factor: 4.244

Review 4.  Genetics of schizophrenia and smoking: an approach to studying their comorbidity based on epidemiological findings.

Authors:  Jose de Leon; Francisco J Diaz
Journal:  Hum Genet       Date:  2011-12-22       Impact factor: 4.132

5.  Smoking among individuals with schizophrenia in Korea: gender differences.

Authors:  Sun S Kim; Sangkeun Chung; Jong-Il Park; Ae-Ja Jung; David Kalman; Douglas M Ziedonis
Journal:  Arch Psychiatr Nurs       Date:  2013-07-26       Impact factor: 2.218

6.  Personalized smoking environment cue reactivity in smokers with schizophrenia and controls: a pilot study.

Authors:  Christopher G Ahnallen; Jennifer W Tidey
Journal:  Psychiatry Res       Date:  2011-05-07       Impact factor: 3.222

7.  The Fagerström test for nicotine dependence: do revisions in the item scoring enhance the psychometric properties?

Authors:  Kristina J Korte; Daniel W Capron; Michael Zvolensky; Norman B Schmidt
Journal:  Addict Behav       Date:  2012-10-29       Impact factor: 3.913

8.  Voxel-based morphometric multisite collaborative study on schizophrenia.

Authors:  Judith M Segall; Jessica A Turner; Theo G M van Erp; Tonya White; H Jeremy Bockholt; Randy L Gollub; Beng C Ho; Vince Magnotta; Rex E Jung; Robert W McCarley; S Charles Schulz; John Lauriello; Vince P Clark; James T Voyvodic; Michele T Diaz; Vince D Calhoun
Journal:  Schizophr Bull       Date:  2008-11-07       Impact factor: 9.306

9.  Smoking expectancies and intention to quit in smokers with schizophrenia, schizoaffective disorder and non-psychiatric controls.

Authors:  Jennifer W Tidey; Damaris J Rohsenow
Journal:  Schizophr Res       Date:  2009-12       Impact factor: 4.939

10.  Combination Extended Smoking Cessation Treatment Plus Home Visits for Smokers With Schizophrenia: A Randomized Controlled Trial.

Authors:  Arthur L Brody; Todd Zorick; Robert Hubert; Gerhard S Hellemann; Shabnam Balali; Sarah S Kawasaki; Lizette Y Garcia; Ryutaro Enoki; Paul Abraham; Paulina Young; Charles McCreary
Journal:  Nicotine Tob Res       Date:  2016-08-03       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.